" The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease (LYLO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01630525 |
Recruitment Status :
Completed
First Posted : June 28, 2012
Last Update Posted : January 25, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Alzheimer's Disease | Other: Neuropsychological assessment Other: ophthalmologic checkup Other: Automated non-invasive oculometry |
Study Type : | Observational |
Actual Enrollment : | 83 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Study Start Date : | December 2012 |
Actual Primary Completion Date : | December 2015 |
Actual Study Completion Date : | December 2015 |

Group/Cohort | Intervention/treatment |
---|---|
Prodromal AD participants |
Other: Neuropsychological assessment
Neuropsychological assessment : MMSE (Greco), RL/RI-16 items (Van der Linden 2003), visual retention test (DMS48), verbal fluency (Thurstone et Thurstone 1964), TMT A and B (Reitan 1956), DSST (Weschler 1997), Clinical Dementia Rating Scale (Hughes 1982), image naming DO80 (Deloche et Hannequin 1997), Similarities and Digit Span subscores of the WAIS (Weschler 1997), Anxiety and Depression (GDS), activities of daily living (ADL-Katz and IADL-Lawton). Other: ophthalmologic checkup Vision work-up, 30 minutes (VA, non invasive retinal imaging : non dilated optic fundus picture or OCT, ocular tension). Other: Automated non-invasive oculometry Automated non-invasive oculometry : 45 minutes with rest periods : horizontal and vertical pro- and anti-saccades, prediction, spatial decision (Monsiman et al. Brain 2005,128:1267-127, items detection (Rösler et al. Cortex 2005 ;41 :512-519) and exploration/curiosity of non congruent images and faces according to Daffner et al. Neurology 1992 ;42 :320-328 and Loughland et al. Biol Psychiatry 2002 ;52 : 338-348). |
Typical AD participants |
Other: Neuropsychological assessment
Neuropsychological assessment : MMSE (Greco), RL/RI-16 items (Van der Linden 2003), visual retention test (DMS48), verbal fluency (Thurstone et Thurstone 1964), TMT A and B (Reitan 1956), DSST (Weschler 1997), Clinical Dementia Rating Scale (Hughes 1982), image naming DO80 (Deloche et Hannequin 1997), Similarities and Digit Span subscores of the WAIS (Weschler 1997), Anxiety and Depression (GDS), activities of daily living (ADL-Katz and IADL-Lawton). Other: ophthalmologic checkup Vision work-up, 30 minutes (VA, non invasive retinal imaging : non dilated optic fundus picture or OCT, ocular tension). Other: Automated non-invasive oculometry Automated non-invasive oculometry : 45 minutes with rest periods : horizontal and vertical pro- and anti-saccades, prediction, spatial decision (Monsiman et al. Brain 2005,128:1267-127, items detection (Rösler et al. Cortex 2005 ;41 :512-519) and exploration/curiosity of non congruent images and faces according to Daffner et al. Neurology 1992 ;42 :320-328 and Loughland et al. Biol Psychiatry 2002 ;52 : 338-348). |
Control participants |
Other: Neuropsychological assessment
Neuropsychological assessment : MMSE (Greco), RL/RI-16 items (Van der Linden 2003), visual retention test (DMS48), verbal fluency (Thurstone et Thurstone 1964), TMT A and B (Reitan 1956), DSST (Weschler 1997), Clinical Dementia Rating Scale (Hughes 1982), image naming DO80 (Deloche et Hannequin 1997), Similarities and Digit Span subscores of the WAIS (Weschler 1997), Anxiety and Depression (GDS), activities of daily living (ADL-Katz and IADL-Lawton). Other: ophthalmologic checkup Vision work-up, 30 minutes (VA, non invasive retinal imaging : non dilated optic fundus picture or OCT, ocular tension). Other: Automated non-invasive oculometry Automated non-invasive oculometry : 45 minutes with rest periods : horizontal and vertical pro- and anti-saccades, prediction, spatial decision (Monsiman et al. Brain 2005,128:1267-127, items detection (Rösler et al. Cortex 2005 ;41 :512-519) and exploration/curiosity of non congruent images and faces according to Daffner et al. Neurology 1992 ;42 :320-328 and Loughland et al. Biol Psychiatry 2002 ;52 : 338-348). |
- Saccades execution parameters [ Time Frame: Study visit (Up to 1 month after inclusion) ]
To demonstrate the alteration of saccade execution parameters (latency, velocity, precision, errors) during pro and anti-saccades, spatial decision and prediction tasks in prodromal AD compared to mild to moderate AD and aged-matched controls.
Variables recorded :
Saccades execution parameters :
- Mean latency (msec),
- Mean velocity (°/msec) and maximal velocity,
- Accuracy or mean gain,
- Mean percent of errors and corrected errors,
- Mean percent of prediction.
- Neuropsychology tests scores [ Time Frame: At inclusion (Day 0) ]
- Pre-defined variables on visual exploration tasks (fixation number and durations, errors). [ Time Frame: Study visit (Up to 1 month after inclusion) ]
- Number of point fixation in degraded areas and of visual attention induced cards [ Time Frame: Study visit (Up to 1 month after inclusion) ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
All patient groups:
- Age >60 years
- Normal vision work-up : (corrected binocular visual acuity > 8/10)
- Written informed consent
- Subjects affiliated to Social Security
Group A: Prodromal AD.
- Memory complaints.
- Normal or slight restriction of IADL.
- "hippocampal-type" amnesic syndrome defined by poor free recall despite adequate (and controlled) encoding, decreased total recall because of insufficient effect of cuing or impaired recognition, numerous intrusions (RL/RI-16items)
- CDR (Clinical Dementia Rating Scale) ≥ 0,5
- Persistence of memory changes at a subsequent assessment (>3 months)
- Absence of global cognitive deterioration (MMSE ≥24)
- Exclusion of other disorders that may cause mild cognitive impairment with adequate tests
- 1.5 Tesla diagnosis MRI with at least T2, Flair transversal sections and coronal T1 sections in the coronal plan. Absent or slight medio temporal/hippocampal atrophy or if available (non mandatory) characteristic CSF betaA42/tau ratio
Group B: Typical AD (mild to moderate)
- NINDS-ADRDA diagnosis criteria
- MMSE ≥ 20
Group C: Control subjects
- No memory or other significant cognitive complain.
- MMSE ≥ 24
Exclusion Criteria:
All groups :
- Clinically significant vision abnormality(P8 without glasses)
- Oculomotor deficit or strabismus
- Depression (GDS) with treatment
- Subjects unable to give their informed consent
Controls :
- Memory or any other significant cognitive complain.
- Abnormalities at inclusion (V0) neuropsychology testing suggestive of a cognitive deficit.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01630525
France | |
Lyon UniversityHospital | |
Lyon, France, 69500 | |
AP-HM | |
Marseille, France, 13385 | |
CHU de Bordeaux Hôpital Haut Lévêque | |
Pessac, France, 33604 |
Principal Investigator: | François TISON, Pr | University Hospital, Bordeaux | |
Study Chair: | Geneviève CHENE, Pr | University Hospital, Bordeaux |
Responsible Party: | University Hospital, Bordeaux |
ClinicalTrials.gov Identifier: | NCT01630525 |
Other Study ID Numbers: |
CHUBX 2011/22 |
First Posted: | June 28, 2012 Key Record Dates |
Last Update Posted: | January 25, 2016 |
Last Verified: | January 2016 |
Alzheimer's disease neurodegenerative signs |
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |